235 related articles for article (PubMed ID: 18347838)
1. Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.
Spellmann I; Müller N; Musil R; Zill P; Douhet A; Dehning S; Cerovecki A; Bondy B; Möller HJ; Riedel M
Eur Arch Psychiatry Clin Neurosci; 2008 Sep; 258(6):335-44. PubMed ID: 18347838
[TBL] [Abstract][Full Text] [Related]
2. Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment.
Spellmann I; Riedel M; Städtler J; Zill P; Obermeier M; Cerovecki A; Dehning S; Schennach R; Epple M; Opgen-Rhein M; Müller N; Bondy B; Möller HJ; Musil R
Cogn Neuropsychiatry; 2017 Jul; 22(4):280-297. PubMed ID: 28470106
[TBL] [Abstract][Full Text] [Related]
3. SNAP-25 gene polymorphisms and weight gain in schizophrenic patients.
Musil R; Spellmann I; Riedel M; Dehning S; Douhet A; Maino K; Zill P; Müller N; Möller HJ; Bondy B
J Psychiatr Res; 2008 Oct; 42(12):963-70. PubMed ID: 18191416
[TBL] [Abstract][Full Text] [Related]
4. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
Riedel M; Spellmann I; Strassnig M; Douhet A; Dehning S; Opgen-Rhein M; Valdevit R; Engel RR; Kleindienst N; Müller N; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
[TBL] [Abstract][Full Text] [Related]
5. [The association of the SNAP-25 gene polymorphism with verbal memory and attention in patients with major psychosis and healthy people].
Golimbet VE; Alfimova MV; Gritsenko IK; Lezheĭko TV; Lavrushina OM; Abramova LI; Kaleda VG; Barkhatova AN; Sokolov AV; Ebshteĭn RP
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):59-63. PubMed ID: 19156089
[TBL] [Abstract][Full Text] [Related]
6. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL
Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421
[TBL] [Abstract][Full Text] [Related]
7. Association between a synaptosomal protein (SNAP-25) gene polymorphism and verbal memory and attention in patients with endogenous psychoses and mentally healthy subjects.
Golimbet VE; Alfimova MV; Gritsenko IK; Lezheiko TV; Lavrushina OM; Abramova LI; Kaleda VG; Barkhatova AN; Sokolov AV; Ebstein RP
Neurosci Behav Physiol; 2010 May; 40(4):461-5. PubMed ID: 20333500
[TBL] [Abstract][Full Text] [Related]
8. Disparate effects of first and second generation antipsychotics on cognition in schizophrenia - Findings from the randomized NeSSy trial.
Veselinović T; Scharpenberg M; Heinze M; Cordes J; Mühlbauer B; Juckel G; Habel U; Rüther E; Timm J; Gründer G;
Eur Neuropsychopharmacol; 2019 Jun; 29(6):720-739. PubMed ID: 30981585
[TBL] [Abstract][Full Text] [Related]
9. A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine.
Stip E; Remington GJ; Dursun SM; Reiss JP; Rotstein E; MacEwan GW; Chokka PR; Jones B; Dickson RA;
J Clin Psychopharmacol; 2003 Aug; 23(4):400-4. PubMed ID: 12920417
[TBL] [Abstract][Full Text] [Related]
10. Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study.
Bervoets C; Morrens M; Vansteelandt K; Kok F; de Patoul A; Halkin V; Pitsi D; Constant E; Peuskens J; Sabbe B
CNS Drugs; 2012 Nov; 26(11):975-82. PubMed ID: 23018547
[TBL] [Abstract][Full Text] [Related]
11. [SNAP-25 and DTNBP1 as candidate genes for cognitive reserve in schizophrenia].
Afimova MV; Golimbet VE; Monakhov MV; Abramova LI; Aksenova EV; Kaleda VG; Velikaia NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(3):54-60. PubMed ID: 23612411
[TBL] [Abstract][Full Text] [Related]
12. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
13. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
[TBL] [Abstract][Full Text] [Related]
14. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia.
Szekeres G; Kéri S; Juhász A; Rimanóczy A; Szendi I; Czimmer C; Janka Z
Am J Med Genet B Neuropsychiatr Genet; 2004 Jan; 124B(1):1-5. PubMed ID: 14681904
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
Rémillard S; Pourcher E; Cohen H
J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
[TBL] [Abstract][Full Text] [Related]
16. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
Torrent C; Martinez-Arán A; Daban C; Amann B; Balanzá-Martínez V; del Mar Bonnín C; Cruz N; Franco C; Tabarés-Seisdedos R; Vieta E
Compr Psychiatry; 2011; 52(6):613-22. PubMed ID: 21295774
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
[TBL] [Abstract][Full Text] [Related]
18. Association among SNAP-25 gene DdeI and MnlI polymorphisms and hemodynamic changes during methylphenidate use: a functional near-infrared spectroscopy study.
Öner Ö; Akın A; Herken H; Erdal ME; Çiftçi K; Ay ME; Bicer D; Öncü B; Bozkurt OH; Münir K; Yazgan Y
J Atten Disord; 2011 Nov; 15(8):628-37. PubMed ID: 20679152
[TBL] [Abstract][Full Text] [Related]
19. The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.
Selva-Vera G; Balanzá-Martínez V; Salazar-Fraile J; Sánchez-Moreno J; Martinez-Aran A; Correa P; Vieta E; Tabarés-Seisdedos R
BMC Psychiatry; 2010 Jun; 10():47. PubMed ID: 20550658
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
